Last quarter (Q1 2024), Enanta Pharmaceuticals's total revenue was $18.00M, a decrease of -11.39% from the same quarter last year. In Q1, Enanta Pharmaceuticals's net income was $-33.41M. See Enanta Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Total Revenue	$ 78.28M	$ 79.20M	$ 86.16M	$ 97.07M	$ 122.47M	$ 205.20M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 78.28M	$ 79.20M	$ 86.16M	$ 97.07M	-	-
Operating Expense	$ 219.34M	$ 216.41M	$ 210.00M	$ 206.65M	$ 164.11M	$ 168.46M
Operating Income	$ -141.06M	$ -137.21M	$ -123.84M	$ -109.57M	$ -41.64M	$ 36.74M
Net Non Operating Interest Income Expense	$ 5.56M	$ 6.21M	$ 1.66M	$ 1.99M	$ 6.47M	$ 8.82M
Other Income Expense	-	-	-	$ 27.00K	$ 149.00K	$ 8.82M
Pretax Income	$ -135.51M	$ -131.00M	$ -122.19M	$ -107.58M	$ -35.02M	$ 45.56M
Tax Provision	$ 3.61M	$ 2.82M	$ -433.00K	$ -28.58M	$ 1.15M	$ -826.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -139.12M	$ -133.82M	$ -121.75M	$ -79.00M	$ -36.17M	$ 46.38M
Basic EPS	$ -6.62	$ -6.38	$ -5.91	$ -3.92	$ -1.81	$ 2.37
Diluted EPS	$ -6.62	$ -6.38	$ -5.91	$ -3.92	$ -1.81	$ 2.21
Basic Average Shares	$ 83.99M	$ 20.97K	$ 20.60K	$ 20.17K	$ 19.94M	$ 19.58M
Diluted Average Shares	$ 83.99M	$ 20.97K	$ 20.60K	$ 20.17K	$ 19.94M	$ 20.97M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 219.34M	$ 216.41M	$ 210.00M	$ 206.65M	$ 164.11M	$ 168.46M
Net Income From Continuing And Discontinued Operation	$ -139.12M	$ -133.82M	$ -121.75M	$ -79.00M	$ -36.17M	$ 46.38M
Normalized Income	$ -62.18M	$ -103.49M	-	-	$ -36.28M	$ 46.38M
Interest Expense	-	-	-	-	-	-
EBIT	$ -131.06M	$ -125.85M	$ -122.19M	$ -107.58M	$ -41.64M	$ 36.74M
EBITDA	$ -131.24M	$ -126.33M	$ -118.04M	$ -102.13M	$ -37.99M	$ 40.00M

Currency in USD

Enanta Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing